Clinical Trial Update: Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating telbivudine in children and adolescents with compensated chronic hepatitis B; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Hepatitis B | Phase 3 | Status: TERMINATED | Results posted: 2019-09-10